News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioMidwest
Baxter International, Inc. to Present at the Barclays Capital 2012 Global Healthcare Conference
February 29, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at Barclays Capital 2012 Global Healthcare Conference on Wednesday, March 14, 2012, at 10:15 a.m. (ET).
Twitter
LinkedIn
Facebook
Email
Print
Events
Baxter International, Inc.
MORE ON THIS TOPIC
Pancreatic cancer
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer
June 25, 2026
·
2 min read
·
Tristan Manalac
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst
Antibody-drug conjugate
Can ADCs be kinder and gentler? Join
BioSpace
at BIO to find out
June 23, 2026
·
3 min read
·
Annalee Armstrong
Drug pricing
BIO 2026: Biopharma dealmakers seek to protect ‘premium pricing’ from Trump’s MFN policy
June 23, 2026
·
2 min read
·
Annalee Armstrong